High molar activity [11C]phosgene and its utilization in the synthesis of radiopharmaceuticals
Description of the granted funding
Carbon is present everywhere in the living nature and 11C-labelled molecules will behave the same way, chemically and biologically, as their unlabelled equivalents. This feature makes carbon-11 such an attractive radionuclide for positron emission tomography (PET). PET is a non-invasive functional and metabolic imaging technique that allows the quantification of biological and pharmacological processes in vivo. Because of the short half-life of carbon-11, rapid and efficient synthesis and analytical processes are needed. The aim of this project is to develop simple, robust and reliable automated synthesis methods to produce high molar activity [11C]phosgene, a secondary synthon for 11C-labelling, by utilizing excitation methods, such as high voltage discharge and UV-photons. A successful project can revolutionize the carbon-11 labelling chemistry of PET-radiopharmaceuticals with high molar activity and radiochemical yield.
Show moreStarting year
2020
End year
2024
Granted funding
Other information
Funding decision number
332128
Fields of science
Chemical sciences
Research fields
Kemia
Identified topics
molecular biology, biochemistry